Skip to content

Venous Site for Central Catheterization

Comparison of Subclavian, Femoral and Internal Jugular Venous Catheterization in Term of Complications in the Intensive Care Unit: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01479153
Acronym
3SITES
Enrollment
3471
Registered
2011-11-24
Start date
2011-10-31
Completion date
2015-02-28
Last updated
2016-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheterization, Critical Care, ICU

Keywords

Central venous catheterization, Major complications, Internal Jugular, Femoral, Subclavian

Brief summary

Central venous catheters are needed in the critical care setting to administer drugs. Three sites are available to gain vascular access: subclavian, internal jugular and femoral. Each site has complications, but there is no randomized controlled study which compared the 3 sites. The investigators hypothesis is that subclavian catheterization reduces the risk of major complications compared to internal jugular or femoral.

Interventions

PROCEDURERandomization of the site for catheterization

Ultra-sound guided insertion strongly recommended

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient admitted in the Intensive Care Unit * Requiring Central Venous Catheterization

Exclusion criteria

* Patients with only one site available

Design outcomes

Primary

MeasureTime frameDescription
Major complications including catheter-related bloodstream infectionFrom central catheter insertion to 48-h after removalCatheter-related bloodstream infection: (positive catheter-tip quantitative culture plus positive peripheral blood culture(s))

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026